Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5ec699c96c809fdf202410d55b5cd797 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D261-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D261-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D261-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D261-02 |
filingDate |
2006-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2010-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_62d09f9d8b0a8837127439abf596272f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b75d9de8c7b3614d858edeab7245e21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b5fa2edce69da806cd70239ba3606c0e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e663c4c0dfdc0bd995465530c1329e40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_35977933088fbce980be7a467778c018 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bc8c2ca7f6f22f23e07ea180782e4d7c |
publicationDate |
2010-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-7842815-B2 |
titleOfInvention |
Compounds and methods for inhibiting the interaction of BCL proteins with binding partners |
abstract |
One aspect of the present invention relates to heterocyclic compounds that bind to bcl proteins and inhibit Bcl function. Another aspect of the present invention relates to compositions comprising a heterocyclic compound of the invention. The present invention provides methods for treating and modulating disorders associated with hyperproliferation, such as cancer. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022008464-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021233948-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3669881-A1 |
priorityDate |
2004-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |